The incidence of pediatric thyroid cancer is relatively low compared to the disease in adults. This study aims to present the data in our institution on pediatric thyroid cancer patients, with particular emphasis on the risk factors of recurrence together with treatment outcomes.
Subjects and Methods:
Between January 2000 and July 2018, patients <20 years who were diagnosed with thyroid carcinoma and primarily treated with surgery at a major large-volume tertiary medical center specializing in thyroid cancer were enrolled. A total of 83 patients were eligible for this study.
Results:
The majority of the studied patients were girls and adolescents (age ≥13 years). Papillary thyroid carcinoma (PTC) was the most common pathology (n = 74). PTC tumors >1 cm showed higher rate of lymph node metastasis and extrathyroidal extension than tumors ≤1 cm. All patients survived with nine PTC patients who displayed treatment failure. Age, tumor size, multifocality, lateral lymph node metastasis, and postoperative thyroglobulin levels were significant prognosticators for disease recurrence.
Conclusion:
Pediatric thyroid cancer is relatively rare and should be considered a specific disease entity with respect to the thyroid cancer in adults, since there are several distinctive characteristics.
NooneAMHowladerNKrapchoM, et al. SEER Cancer Statistics Review, 1975-2015. Bethesda, MD: National Cancer Institute, https://seer.cancer.gov/csr/1975_2015/, based on November 2017 SEER data submission, posted to the SEER web site, April 2018.
2.
HoganARZhugeYPerezEAKoniarisLGLewJISolaJE.Pediatric thyroid carcinoma: incidence and outcomes in 1753 patients. J Surg Res. 2009;156(1):167-172.
3.
WuXCChenVWSteeleB, et al. Cancer incidence in adolescents and young adults in the United States, 1992-1997. J Adolesc Health. 2003;32(6):405-415.
4.
WardEDeSantisCRobbinsAKohlerBJemalA.Childhood and adolescent cancer statistics, 2014. CA Cancer J Clin. 2014;64(2):83-103.
5.
DemidchikYESaenkoVAYamashitaS.Childhood thyroid cancer in Belarus, Russia, and Ukraine after Chernobyl and at present. Arq Bras Endocrinol Metabol. 2007;51(5):748-762.
6.
MonacoSEPantanowitzLKhalbussWE, et al. Cytomorphological and molecular genetic findings in pediatric thyroid fine-needle aspiration. Cancer Cytopathol. 2012;120(5):342-350.
7.
HarnessJKThompsonNWMcLeodMKPasiekaJLFukuuchiA.Differentiated thyroid carcinoma in children and adolescents. World J Surg. 1992;16(4):547-553.
8.
PopovtzerAShpitzerTBaharGFeinmesserRSegalK.Thyroid cancer in children: management and outcome experience of a referral center. Otolaryngol Head Neck Surg. 2006;135(4):581-584.
9.
GorlinJBSallanSE.Thyroid cancer in childhood. Endocrinol Metab Clin North Am. 1990;19(3):649-662.
10.
KarapanouOTzanelaMVlassopoulouBKanaka-GantenbeinC.Differentiated thyroid cancer in childhood: a literature update. Hormones (Athens). 2017;16(4):381-387.
11.
CibasESAliSZ.The 2017 Bethesda System for Reporting Thyroid Cytopathology. Thyroid. 2017;27(11):1341-1346.
12.
GharibHGoellnerJRJohnsonDA.Fine-needle aspiration cytology of the thyroid. A 12-year experience with 11,000 biopsies. Clin Lab Med. 1993;13(3):699-709.
13.
TuttleRMLemarHBurchHB.Clinical features associated with an increased risk of thyroid malignancy in patients with follicular neoplasia by fine-needle aspiration. Thyroid. 1998;8(5):377-383.
14.
NiedzielaM.Pathogenesis, diagnosis and management of thyroid nodules in children. Endocr Relat Cancer. 2006;13(2):427-453.
15.
GuptaALySCastronevesLA, et al. A standardized assessment of thyroid nodules in children confirms higher cancer prevalence than in adults. J Clin Endocrinol Metab. 2013;98(8):3238-3245.
16.
PartykaKLHuangECCramerHMChenSWuHH.Histologic and clinical follow-up of thyroid fine needle aspirates in pediatric patients. Cancer Cytopathol. 2016;124(7):467-471.
17.
HaugenBRAlexanderEKBibleKC, et al. 2015 American Thyroid Association Management Guidelines for adult patients with thyroid nodules and differentiated thyroid cancer: The American Thyroid Association Guidelines Task Force on thyroid nodules and differentiated thyroid cancer. Thyroid. 2016;26(1):1-133.
18.
FrancisGLWaguespackSGBauerAJ, et al. Management guidelines for children with thyroid nodules and differentiated thyroid cancer. Thyroid. 2015;25(7):716-759.
19.
HuangLYLeeYLChouPChiuWYChuD.Thyroid fine-needle aspiration biopsy and thyroid cancer diagnosis: a nationwide population-based study. PLoS One. 2015;10(5):e0127354.
20.
WadaNSuginoKMimuraT, et al. Treatment strategy of papillary thyroid carcinoma in children and adolescents: clinical significance of the initial nodal manifestation. Ann Surg Oncol. 2009;16(12):3442-3449.
21.
SavioRGosnellJPalazzoFF, et al. The role of a more extensive surgical approach in the initial multimodality management of papillary thyroid cancer in children. J Pediatr Surg. 2005;40(11):1696-1700.
22.
NewmanKDBlackTHellerG, et al. Differentiated thyroid cancer: determinants of disease progression in patients <21 years of age at diagnosis: a report from the Surgical Discipline Committee of the Children’s Cancer Group. Ann Surg. 1998;227(4):533-541.
23.
FrankenthalerRASellinRVCangirAGoepfertH.Lymph node metastasis from papillary-follicular thyroid carcinoma in young patients. Am J Surg. 1990;160(4):341-343.
24.
BongarzoneIFugazzolaLVigneriP, et al. Age-related activation of the tyrosine kinase receptor protooncogenes RET and NTRK1 in papillary thyroid carcinoma. J Clin Endocrinol Metab. 1996;81(5):2006-2009.
25.
YamashitaSSaenkoV.Mechanisms of disease: molecular genetics of childhood thyroid cancers. Nat Clin Pract Endocrinol Metab. 2007;3(5):422-429.
26.
FentonCLLukesYNicholsonDDinauerCAFrancisGLTuttleRM.The ret/PTC mutations are common in sporadic papillary thyroid carcinoma of children and young adults. J Clin Endocrinol Metab. 2000;85(3):1170-1175.
27.
NikiforovYERowlandJMBoveKEMonforte-MunozHFaginJA.Distinct pattern of ret oncogene rearrangements in morphological variants of radiation-induced and sporadic thyroid papillary carcinomas in children. Cancer Res. 1997;57(9):1690-1694.
28.
MazzaferriEL.Management of low-risk differentiated thyroid cancer. Endocr Pract. 2007;13(5):498-512.
29.
HayID.Management of patients with low-risk papillary thyroid carcinoma. Endocr Pract. 2007;13(5):521-533.
30.
PawelczakMDavidRFranklinBKesslerMLamLShahB.Outcomes of children and adolescents with well-differentiated thyroid carcinoma and pulmonary metastases following 131I treatment: a systematic review. Thyroid. 2010;20(10):1095-1101.
31.
Welch DinauerCATuttleRMRobieDK, et al. Clinical features associated with metastasis and recurrence of differentiated thyroid cancer in children, adolescents and young adults. Clin Endocrinol (Oxf). 1998;49(5):619-628.
32.
O’GormanCSHamiltonJRachmielMGuptaANganBYDanemanD.Thyroid cancer in childhood: a retrospective review of childhood course. Thyroid. 2010;20(4):375-380.
